3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Neoplasm Metastasis
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Prostate Adenocarcinoma
1
PSA Level Greater Than Two
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Carcinoma, Renal Cell
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
Paclitaxel
22
Bevacizumab
20
Carboplatin
19
liposomal doxorubicin
14
Specimen Handling
14
Magnetic Resonance Spectroscopy
13
olaparib
12
Topotecan
9
Gemcitabine
9
Biopsy
8
pembrolizumab
7
Taxes
6
Immunoglobulin G
6
Disulfides
6
niraparib
4
mirvetuximab soravtansine
4
cediranib
4
Doxorubicin
4
oregovomab
3
Nivolumab
3
Cyclophosphamide
3
sarilumab
2
rucaparib
2
cemiplimab
2
berzosertib
2
adavosertib
2
Oxaliplatin
2
Docetaxel
2
Cisplatin
2
Biosimilar Pharmaceuticals
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
bicalutamide
×
90 days
×
Clear all
No trials found.